CHInese Medicine NeuroAid Efficacy on Stroke Recovery
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
CHIMES is a double blind, placebo controlled, randomized, multicenter study to test the
hypothesis that NeuroAid is superior to placebo in reducing neurological deficit and
improving functional outcome in patients with cerebral infarction of an intermediate range of
severity.
Phase:
Phase 3
Details
Lead Sponsor:
CHIMES Society
Collaborator:
National Medical Research Council (NMRC), Singapore